Description

INH IPRATROP DUO is a highly effective respiratory solution combining Ipratropium Bromide (20 mg) and Levosalbutamol (50 mcg) for the management of chronic respiratory conditions. This dual-action medication is specially formulated for patients suffering from Chronic Obstructive Pulmonary Disease (COPD), asthma, and other breathing disorders. Ipratropium Bromide is an anticholinergic bronchodilator that relaxes the muscles of the airways, reducing bronchospasm, while Levosalbutamol, a short-acting beta2-agonist, works quickly to open the air passages and ease breathing. Together, they provide rapid and sustained relief from breathing difficulties, ensuring improved lung function and enhanced quality of life. Uses INH IPRATROP DUO is indicated for: Relief and management of COPD, including chronic bronchitis and emphysema. Treatment of asthma and prevention of acute asthma attacks. Management of wheezing, shortness of breath, and chest tightness. Bronchodilation therapy for patients requiring rapid relief and maintenance of airway openness. Improvement in overall lung function and oxygen intake for individuals with respiratory disorders. This solution is administered via a nebulizer, making it ideal for patients who require inhalation therapy for effective and direct delivery to the lungs. Benefits Dual Bronchodilator Action: Combines the rapid action of Levosalbutamol with the long-lasting effect of Ipratropium Bromide for superior relief. Quick Symptom Relief: Helps relieve wheezing, breathlessness, and chest tightness within minutes. Improves Breathing Efficiency: Supports better airflow and lung function, reducing respiratory strain. Reduces Exacerbations: Regular use may prevent sudden flare-ups of asthma or COPD. Safe and Convenient: Nebulized solution ensures accurate dosing and direct delivery to affected airways. Enhanced Quality of Life: Allows patients to carry out daily activities without constant interruptions from breathing difficulties. Dosage Adults: 1–2 nebulizer doses 3–4 times daily or as prescribed by a healthcare professional. Children: Dosage must be strictly determined by a pediatrician. Shake well before use and connect the solution to a nebulizer for proper inhalation. Inhale slowly and deeply through the mouthpiece until the full dose is administered. Clean the nebulizer equipment after each use to ensure hygiene and prevent infection. Always follow the prescribed regimen for maximum benefit and avoid self-adjusting the dose. Side Effects Common side effects may include: Mild tremors or shaking Headache Throat irritation or cough Dry mouth Nausea or dizziness Rare but serious side effects can include rapid heartbeat, chest pain, or allergic reactions. Seek immediate medical attention if severe symptoms occur. Precautions and Warning Pregnancy & Breastfeeding: Only use under medical supervision. Heart Conditions: Use with caution in patients with heart disease, hypertension, or arrhythmias. Diabetes & Thyroid Disorders: Monitor regularly, as Levosalbutamol may affect blood sugar and thyroid activity. Allergies: Do not use if allergic to Ipratropium, Levosalbutamol, or any other components. Not for Oral Use: This solution is strictly for nebulizer inhalation. Storage: Store in a cool, dry place below 30°C, away from sunlight. Keep out of reach of children. Conclusion INH IPRATROP DUO (Ipratropium Bromide 20 mg + Levosalbutamol 50 mcg Respirator Solution) is a trusted dual-action respiratory solution for rapid and effective relief from asthma and COPD symptoms. By combining the fast-acting bronchodilator Levosalbutamol with the sustained action of Ipratropium Bromide, it ensures improved airflow, reduced flare-ups, and better overall lung health. With proper use as prescribed, INH IPRATROP DUO helps patients breathe comfortably, maintain active lifestyles, and enjoy improved respiratory wellness.